| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8983a064d5a6c9324e4285203084e02a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2010-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc9c44c506f3d860e715c6c681e6c95e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_810e49a5609d827fe0f0adda8b69a831 |
| publicationDate |
2012-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201210616-A |
| titleOfInvention |
Use of CD13 receptor for preparing drug for inhibiting Mycobacterium tuberculosis |
| abstract |
This invention discloses a use of CD13 receptor for preparing a drug for inhibiting Mycobacterium tuberculosis, using at least an anti-CD13 antibody to be combined to a CD13 receptor of a cell to inhibit the cell from being infected by Mycobacterium tuberculosis, wherein the anti-CD13 antibody is WM15 antibody or WM47 antibody. The application of anti-CD13 antibody can lower the CD-13 expression and inhibit the Mycobacterium from entering monocyte or surviving in the monocyte, capable of effectively killing the Mycobacterium tuberculosis. |
| priorityDate |
2010-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |